by Elana GotkineFor adults with mild-to-moderate COVID-19, early administration of simnotrelvir plus ritonavir shortens the time to sustained resolution of symptoms, according to a study published in
by Elana GotkineFor adults with mild-to-moderate COVID-19, early administration of simnotrelvir plus ritonavir shortens the time to sustained resolution of symptoms, according to a study published in
by Ben-Gurion University of the NegevCellulose degrading gut bacteria of hominids across evolutionary time. Previously unknown human gut cellulolytic ruminococcal species are highly prevalent in
by Ben-Gurion University of the NegevCellulose degrading gut bacteria of hominids across evolutionary time. Previously unknown human gut cellulolytic ruminococcal species are highly prevalent in
by Shalini Arunogiri, Leigh Walker and Roberta Anversa,The ConversationCredit: Markus Winkler from PexelsSemaglutide (sold as Ozempic, Wegovy and Rybelsus) was initially developed to treat diabe
by Shalini Arunogiri, Leigh Walker and Roberta Anversa,The ConversationCredit: Markus Winkler from PexelsSemaglutide (sold as Ozempic, Wegovy and Rybelsus) was initially developed to treat diabe
Scientists have figured out how to see through mice—could humans be next?by Timothy Hearn,The ConversationHow tartrazine made mice see-through under certain light. Credit:ScienceImagine be
Scientists have figured out how to see through mice—could humans be next?by Timothy Hearn,The ConversationHow tartrazine made mice see-through under certain light. Credit:ScienceImagine be
by AudioCure Pharma GmbHThe effect of AC102 on OHC survival after noise exposure in vivo. (A) Schematic of OHCs and IHCs within the cochlea. (B) Quantification of OHCs 14 d after noise exposure reveal
by AudioCure Pharma GmbHThe effect of AC102 on OHC survival after noise exposure in vivo. (A) Schematic of OHCs and IHCs within the cochlea. (B) Quantification of OHCs 14 d after noise exposure reveal
by Impact Journals LLCWorkflow illustration. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28459A new editorial paper titled "The double-edge sword of CRISPR application for in vi
by Impact Journals LLCWorkflow illustration. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28459A new editorial paper titled "The double-edge sword of CRISPR application for in vi
by Lori SolomonThe U.S. Food and Drug Administration has approved Duvyzat (givinostat) as an oral medication for the treatment of Duchenne muscular dystrophy (DMD) in patients six years of age and old
by Lori SolomonThe U.S. Food and Drug Administration has approved Duvyzat (givinostat) as an oral medication for the treatment of Duchenne muscular dystrophy (DMD) in patients six years of age and old
byUniversity of CologneCredit:Cell Chemical Biology(2024). DOI: 10.1016/j.chembiol.2023.12.007Researchers have identified new antibiotic molecules that target Mycobacterium tuberculo
byUniversity of CologneCredit:Cell Chemical Biology(2024). DOI: 10.1016/j.chembiol.2023.12.007Researchers have identified new antibiotic molecules that target Mycobacterium tuberculo
byBritish Medical JournalCredit: Pixabay/CC0 Public DomainImplementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, s
byBritish Medical JournalCredit: Pixabay/CC0 Public DomainImplementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, s